AKESOgen Ranks as the No. 23 Healthcare Company and 240th Overall on the 2016 Inc.500 with Three-Year Sales Growth of 1,615%
NEW YORK and ATLANTA August 17, 2016 – Inc. magazine today ranked AKESOgen, 23rd as a Healthcare company and 240th overall on its 35th annual Inc. 500, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment— its independent small businesses. Companies such as Microsoft, Dell, Domino’s Pizza, Pandora, Timberland, LinkedIn, Yelp, Zillow, and many other well-known names gained their first national exposure as honorees of the Inc. 500|5000.
“Once again, we are delighted to be recognized for the second consecutive year as an Inc.500 honoree with such well known organizations in 2016 as Square, Dollar Shave Club, ipsy and Yeti Cooler.” commented AKESOgen CEO Robert Boisjoli.
“We are fortunate to be in a business which is at the forefront of providing the latest molecular technologies for 21st century personalized medicine. The knowledge and impact of DNA and our own genetic makeup is becoming more and more a part of our everyday lives and will only continue to increase. AKESOgen is providing new cutting edge genomic tools and services to enable this emerging approach to science.” says Mark Bouzyk, PhD, AKESOgen’s Chief Scientific Officer.
The 2016 Inc. 5000, unveiled online at Inc.com and with the top 500 companies featured in the September issue of Inc. (available on newsstands August 23) is the most competitive crop in the list’s history. The average company on the list achieved a mind-boggling three-year growth of 433%. The Inc. 5000’s aggregate revenue is $200 billion, and the companies on the list collectively generated 640,000 jobs over the past three years, or about 8% of all jobs created in the entire economy during that period. Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at www.inc.com/inc5000.
“The Inc. 5000 list stands out where it really counts,” says Inc. President and Editor-In-Chief Eric Schurenberg. “It honors real achievement by a founder or a team of them. No one makes the Inc. 5000 without building something great – usually from scratch. That’s one of the hardest things to do in business, as every company founder knows. But without it, free enterprise fails.”
About Inc. Media:
Founded in 1979 and acquired in 2005 by Mansueto Ventures, Inc. is the only major brand dedicated exclusively to owners and managers of growing private companies, with the aim to deliver real solutions for today’s innovative company builders. Winner of the National Magazine Award for General Excellence in both 2014 and 2012. Total monthly audience reach for the brand has grown significantly from 2,000,000 in 2010 to over 15,000,000 today. For more information, visit www.inc.com.
For more information contact:
About AKESOgen, Inc.
AKESOgen is an integrated Clinical Laboratory Improvement Amendments (CLIA) compliant and College of American Pathology (CAP) accredited genomics, genetics and bio-banking company that services the pharmaceutical, biotechnology, clinical, academic, and government sectors for clinical trials, diagnostic clinical testing, and research. Based in Atlanta, GA, USA, the company’s main focus is oncology and personalized medicine. AKESOgen’s services include providing high-throughput, biomarker profiling, cytogenetic arrays, sequencing, and genomics analysis utilizing different types of markers (e.g. DNA, mRNA, miRNA, and methylation). For more information, visit www.akesogen.com.
Marissa Cooke, Client Relations Specialist, Scientific Affairs, AKESOgen, Inc. +1 770-542-0890, or email@example.com